Medical Condition News

RSS

UMN researchers develop new way to study cancer cells in a 3D in vitro model

University of Minnesota researchers have developed a way to study cancer cells which could lead to new and improved treatment. They have developed a new way to study these cells in a 3D in vitro model (i.e. in a culture dish rather than in a human or animal).

12 Feb 2019

Cancer-promoting changes seen in lung cells soon after exposure to low-molecular weight PAHs

It is well known that exposure to high-molecular weight polycyclic aromatic hydrocarbons increases cancer risk, leading to regulation of compounds like benzo(a)pyrene.

12 Feb 2019

Research reveals critical immunological axis that triggers cancer-promoting chronic inflammation

A Massachusetts General Hospital research team has identified interaction between two elements of the immune system as critical for the transformation of a protective immune response into chronic, cancer-promoting inflammation.

12 Feb 2019

Researchers to investigate light therapy as relief from painful side effect of cancer treatment

University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.

12 Feb 2019

NIH and partners host meeting to discuss the future of spinal cord injury research

The National Institutes of Health (NIH) and its partners will host a meeting of researchers, clinicians, patients and patient advocates to discuss spinal cord injury (SCI) research and to chart a course of future studies.

12 Feb 2019

Protein released from fat in response to exercise improves health

It's well-known that exercise improves health, but understanding how it makes you healthier on a molecular level is the question researchers at Joslin Diabetes Center are answering.

12 Feb 2019

Brain protein critical to recovery from stroke identified

Every 40 seconds, someone in the United States suffers a stroke and available therapies, such as clot busting drugs or clot removal devices, are focused on limiting the extent of brain damage.

12 Feb 2019

Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s

Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.

12 Feb 2019

Immunotherapy drug can be effective in treating patients with recurrent brain tumors

A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before surgery is more effective than using the drug afterward.

11 Feb 2019

Watchful waiting in prostate cancer becoming more popular

In 2010, the US National Comprehensive Cancer Network guidelines suggested that patients with stable and low-risk prostate cancers could be managed with active surveillance or watchful waiting (AS/WW). AS/WW was considered to be a safe and effective alternative to aggressive surgery to remove the prostate and radiation therapy.

11 Feb 2019

Trojan Horse approach to cancer therapy shows promise

A new form of cancer fighting drug has been developed using the principles of the “Trojan Horse”.

11 Feb 2019

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

As marijuana legalization sweeps North America, use of the substance has been on the rise, and the public's attitude is shifting. An increasing number of people believe that "weed" is the safest recreational drug, one that carries health benefits that outweigh its risks.

11 Feb 2019

New target appears to aid recovery after optic nerve trauma

When a car crash or explosion results in an optic nerve injury, eliminating an enzyme known to promote inflammation appears to aid recovery, scientists report.

11 Feb 2019

Acute Cardiovascular Care 2019 will highlight latest advances covering heart problems

Is it better to have a heart attack while traveling or at home? Find out at Acute Cardiovascular Care 2019.

11 Feb 2019

Early human testing of iron chelation after brain bleed shows mixed results

A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

11 Feb 2019

Bone marrow disease is stimulated by vitamin D and immune cells, reveals research

The bone marrow disease myelofibrosis is stimulated by excessive signaling from vitamin D and immune cells known as macrophages, reveals a Japanese research team. These findings could help to develop alternative treatments that do not target problem genes.

11 Feb 2019

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.

11 Feb 2019

Medical Condition News

UMN researchers develop new way to study cancer cells in a 3D in vitro model

Cancer-promoting changes seen in lung cells soon after exposure to low-molecular weight PAHs

Research reveals critical immunological axis that triggers cancer-promoting chronic inflammation

Researchers to investigate light therapy as relief from painful side effect of cancer treatment

NIH and partners host meeting to discuss the future of spinal cord injury research

Protein released from fat in response to exercise improves health

Brain protein critical to recovery from stroke identified

Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s

Immunotherapy drug can be effective in treating patients with recurrent brain tumors

Watchful waiting in prostate cancer becoming more popular

Trojan Horse approach to cancer therapy shows promise

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

New target appears to aid recovery after optic nerve trauma

Acute Cardiovascular Care 2019 will highlight latest advances covering heart problems

Early human testing of iron chelation after brain bleed shows mixed results

Bone marrow disease is stimulated by vitamin D and immune cells, reveals research

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

New heated tobacco device is as toxic as vaping and traditional cigarettes

New findings could provide novel approach to target and destroy cancer cells

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News